Global HEOR Services Market Size Likely to Grow at a CAGR of 13.5% By 2034

Market Size and Growth

As per the HEOR Services Market size analysis conducted by the CMI Team, the global Health economics and outcomes research (HEOR) services market is expected to record a CAGR of 13.5% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 1.9 billion. By 2034, the valuation is anticipated to reach USD 8.5 billion.

Overview

According to industry experts at CMI, the HEOR services market is witnessing steady growth due to the growing interest of pharmaceuticals, biotechnology, healthcare providers, and payer organizations in the adoption of the services. The world leaders in the industry, including IQVIA, Parexel, ICON plc, and Syneos Health, are investing in data solutions with advanced analytics, real-world evidence platforms, and AI-enabled solutions.

North America focuses on high compliance with regulations and cast-iron healthcare infrastructure, whereas Europe is focused on cost-effectiveness research, sustainability, and healthcare efficiency programs. The Asia-Pacific market is the rapidly developing market driven by the growth of healthcare, increased investments in R&D, and favorable government policies. The partnerships between service providers, research organizations, and regulatory agencies are becoming strategic and stronger in terms of innovation, better patient-centric outcomes and competitiveness on the international level.

Key Trends & Drivers

• Shifting Focus Towards the Benefits of Value Healthcare: In the healthcare industry, payment for services is increasingly being tied to patient outcomes rather than the payment for services rendered. This trend focuses deeply on the treatment’s costs, quality, and effectiveness. HEOR services support biopharma companies in establishing the clinical and economic worth, and the broader social impact, of drugs and medical devices. The increasing demand for HEOR services stems from payers and healthcare providers needing health economic data to support their reimbursement and pricing strategies. In the pursuit of sustainability and patient-centered values, HEOR is increasingly used in resource allocation in health systems to support the rising demand for evidence-based approaches from governments and health insurers.

• Increased Use of Real-World Evidence (RWE): Real-world evidence (RWE) is crucial in illustrating the long-term safety and effectiveness, as well as the economic impact, of any healthcare intervention. Even the FDA and EMA are beginning to use RWE in decision-making processes that go beyond standard clinical trials. HEOR services provide market access by collecting, synthesizing, and analyzing electronic health records, patient registries, wearables, claims databases, and other data to form a comprehensive perspective on patient outcomes in real-world scenarios. This not only facilitates market access but also enhances RWE-driven post-launch surveillance, pricing, and comparative effectiveness studies. The increased confidence in RWE for regulatory submission and reimbursement approval to HEOR services is propelling the demand for these services in the global market. This keeps the market for them growing, and is helping the HEOR market as a whole.

• Technological Expansion in AI and Big Data Analytics: In this age, most industries are influenced by the application of AI, machine learning, and big data analytics tools. While in the past HEOR put great focus on the use of traditional methods with a great deal of manual work, current analytics technologies are capable of handling and simplifying even the most complex health care data sets. With the help of predictive modeling, simulation of patient outcomes, cost-effectiveness analyses, and the forecasting of challenges associated with market access are now possible. There is also the added advantage of AI driven platforms that foster insights in a way that High Trust stakeholders, in particular, are able to make evidence-based clinical and economic decisions with greater speed, accuracy, and transparency on complex issues. In the same way, HEOR is made more robust and dependable by seamless integration with other forms, such as IoT, cloud computing, and e-health tools. Such same-day integration simplifies data collection and more detailed analysis. Such advances in HEOR are driven by a desire to increase evidence-based strategies in healthcare, which is a solid threat that keeps on evolving.

Report Scope

SWOT Analysis

• Strengths: The market of HEOR services is characterized by the increase in demand of real-world evidence, cost-effective analysis, and value-based healthcare. Established providers have good analytics platforms, regulatory knowledge, and associations with pharma and payers, and can correctly make insights, quicker studies, and reliability in assisting pricing, reimbursement, and accessibility strategies in the global market.

• Weaknesses: This is due to overdependence on specialized talent and complicated analytics infrastructure, which raises operational expenses. Smaller providers might have difficulties in scaling, adopting a wide range of datasets, and keeping up with changing regional regulations. Lack of standardization of methods may have an impact on consistency, slowing newcomers and modifying competitive benefits to middle-sized companies.

• Opportunities: With the increased use of AI, machine learning, and big data analytics, there will be an opportunity to enhance predictive modeling, outcomes measurement, and patient-centered research. Growth in new markets such as Asia-Pacific has unexploited potential with the growing healthcare, increasing pharmaceutical expenditures, and the new government's emphasis on evidence-based decision-making, which enable quicker market entry and diversification of services.

• Threats: Threats to market operations include regulatory uncertainties, data privacy regulations, and payer inconsistency requirements. Global analytics companies and consulting providers may apply pressure on margins. Moreover, client approvals, disjointed healthcare data, and integration difficulties can obstruct the provision of actionable insights on time, which can affect reputation and contracts in the long term.

List of the prominent players in the HEOR Services Market:

• McKesson Corporation
• Axtria
• Cardinal Health
• Avalon Health Economics
• MEDLIOR
• IQVIA
• PharmaLex GmbH
• Syneos Health
• RTI Health Solutions
• ICON plc
• PPD Inc
• Others

The HEOR Services Market is segmented as follows:

By Service

• Economic Modelling/ Evaluation
• Real-World Data Analysis and Information Systems
• Clinical Outcome
• Market Access Solutions and Reimbursement
• Others

By Service Provider

• Consultancy
• Contract Research Organizations (CROs)

By End-use

• Healthcare Providers
• Healthcare Payers
• Biotech/Pharma Companies
• Government Organizations
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America